Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Review of red yeast rice content and current Food and Drug Administration oversight.

Childress L, Gay A, Zargar A, Ito MK.

J Clin Lipidol. 2013 Mar-Apr;7(2):117-22. doi: 10.1016/j.jacl.2012.09.003. Epub 2012 Sep 25. Review.

PMID:
23415430
2.

Chemical profiling and quantification of monacolins and citrinin in red yeast rice commercial raw materials and dietary supplements using liquid chromatography-accurate QToF mass spectrometry: Chemometrics application.

Avula B, Cohen PA, Wang YH, Sagi S, Feng W, Wang M, Zweigenbaum J, Shuangcheng M, Khan IA.

J Pharm Biomed Anal. 2014 Nov;100:243-53. doi: 10.1016/j.jpba.2014.07.039. Epub 2014 Aug 9.

PMID:
25168220
3.

Simultaneous determination of lovastatin and citrinin in red yeast rice supplements by micellar electrokinetic capillary chromatography.

Nigović B, Sertić M, Mornar A.

Food Chem. 2013 May 1;138(1):531-8. doi: 10.1016/j.foodchem.2012.10.104. Epub 2012 Nov 12.

PMID:
23265521
4.

Marked variability of monacolin levels in commercial red yeast rice products: buyer beware!

Gordon RY, Cooperman T, Obermeyer W, Becker DJ.

Arch Intern Med. 2010 Oct 25;170(19):1722-7. doi: 10.1001/archinternmed.2010.382.

PMID:
20975018
5.

Red yeast rice for the treatment of dyslipidemia.

Burke FM.

Curr Atheroscler Rep. 2015 Apr;17(4):495. doi: 10.1007/s11883-015-0495-8. Review.

PMID:
25728312
6.

An analysis of nine proprietary Chinese red yeast rice dietary supplements: implications of variability in chemical profile and contents.

Heber D, Lembertas A, Lu QY, Bowerman S, Go VL.

J Altern Complement Med. 2001 Apr;7(2):133-9.

PMID:
11327519
7.

The effect of red yeast rice (Monascus purpureus) in dyslipidemia and other disorders.

Yang CW, Mousa SA.

Complement Ther Med. 2012 Dec;20(6):466-74. doi: 10.1016/j.ctim.2012.07.004. Epub 2012 Aug 17. Review.

PMID:
23131380
8.
9.

Pharmacologically effective red yeast rice preparations marketed as dietary supplements illustrated by a case report.

Venhuis BJ, van Hunsel F, van de Koppel S, Keizers PH, Jeurissen SM, De Kaste D.

Drug Test Anal. 2016 Mar-Apr;8(3-4):315-8. doi: 10.1002/dta.1929. Epub 2016 Jan 26.

PMID:
26810781
10.

The impact of cGMP compliance on consumer confidence in dietary supplement products.

Crowley R, FitzGerald LH.

Toxicology. 2006 Apr 3;221(1):9-16. Epub 2006 Feb 15.

PMID:
16469425
11.

Development of a rapid LC/DAD/FLD/MS(n) method for the simultaneous determination of monacolins and citrinin in red fermented rice products.

Mornar A, Sertić M, Nigović B.

J Agric Food Chem. 2013 Feb 6;61(5):1072-80. doi: 10.1021/jf304881g. Epub 2013 Jan 24.

PMID:
23305336
12.

Fast screening of lovastatin in red yeast rice products by flow injection tandem mass spectrometry.

Song F, El-Demerdash A, Lee SJ, Smith RE.

J Pharm Biomed Anal. 2012 Jan 5;57:76-81. doi: 10.1016/j.jpba.2011.08.039. Epub 2011 Sep 2.

PMID:
21943718
13.

Functional food red yeast rice (RYR) for metabolic syndrome amelioration: a review on pros and cons.

Patel S.

World J Microbiol Biotechnol. 2016 May;32(5):87. doi: 10.1007/s11274-016-2035-2. Epub 2016 Apr 2. Review.

PMID:
27038957
14.

Anticancer effects of Chinese red yeast rice versus monacolin K alone on colon cancer cells.

Hong MY, Seeram NP, Zhang Y, Heber D.

J Nutr Biochem. 2008 Jul;19(7):448-58. Epub 2007 Sep 14.

15.

['Red yeast rice' as a cholesterol-lowering substance?Caution is warranted].

Brouwers JR, Roeters van Lennep JE, Maas AH.

Ned Tijdschr Geneeskd. 2016;160(0):D99. Dutch.

PMID:
27438400
17.

Nutravigilance: principles and practices to enhance adverse event reporting in the dietary supplement and natural products industry.

Schmitz SM, Lopez HL, MacKay D.

Int J Food Sci Nutr. 2014 Mar;65(2):129-34. doi: 10.3109/09637486.2013.836743. Epub 2013 Oct 11.

PMID:
24112316
18.

Patient use of dietary supplements: a clinician's perspective.

Sadovsky R, Collins N, Tighe AP, Brunton SA, Safeer R.

Curr Med Res Opin. 2008 Apr;24(4):1209-16. doi: 10.1185/030079908X280743 . Epub 2008 Mar 17. Review.

PMID:
18348745
19.

Improved dissolution rate and oral bioavailability of lovastatin in red yeast rice products.

Chen CH, Yang JC, Uang YS, Lin CJ.

Int J Pharm. 2013 Feb 28;444(1-2):18-24. doi: 10.1016/j.ijpharm.2013.01.028. Epub 2013 Jan 23.

PMID:
23352857
20.

Red Yeast Rice.

Nguyen T, Karl M, Santini A.

Foods. 2017 Mar 1;6(3). pii: E19. doi: 10.3390/foods6030019.

Supplemental Content

Support Center